Education
About Us
Working with TipRanks
Follow Us
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
Cabozantinib, Casdatifan
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
Phase III
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Jun 02, 2025
―
Itraconazole, Phenytoin, Casdatifan
Healthy Participants
Phase I
Active Not Recruiting
Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29)
Mar 27, 2025
―
Gemcitabine, Nab-paclitaxel, Quemliclustat
Metastatic Pancreatic Ductal Adenocarcinoma
Phase III
Active Not Recruiting
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Sep 20, 2024
―
Docetaxel, Ab801
Advanced Cancer
Phase I
Recruiting
A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
Nov 01, 2023
―
Fluorouracil, Oxaliplatin, Leucovorin, Zimberelimab, Ab598
Cervical Cancer, Ovarian Cancer, Bladder Cancer, Non-Small Cell Lung Cancer (Nsclc), Gastric Cancer, Advanced Cancer, Esophageal Cancer, Head And Neck Squamous Cell Carcinoma (Hnscc), Advanced Malignancies, Renal Cell Carcinoma (Rcc), Triple Negative Breast Cancer (Tnbc), Gastroesophageal-Junction Cancer (Gej)
Phase I
Active Not Recruiting
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
May 26, 2023
―
Cabozantinib, Zimberelimab, Casdatifan
Solid Tumors, Clear Cell Renal Cell Carcinoma
Phase I
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Sep 07, 2022
―
Zimberelimab, Etrumadenant, Srf617
Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer
Phase II
Terminated
Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer
Dec 05, 2021
―
Gemcitabine, Nab-paclitaxel, Zimberelimab, Ab680
Advanced Pancreatic Cancer
Phase I
Active Not Recruiting
A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
Sep 23, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Arcus Biosciences Inc (RCUS) have in its pipeline
RCUS is currently developing the following drugs: Cabozantinib, Casdatifan, Itraconazole, Phenytoin, Casdatifan, Gemcitabine, Nab-paclitaxel, Quemliclustat. These drug candidates are in various stages of clinical development as the company works toward FDA approval.